Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in t...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 5, 2023

Coya Therapeutics Strengthens Scientific Advisory Board (SAB) with the Addition of Neuroimmunology Pioneer, Dr. Guillaume Doroth • Dr. Jen Ashton's "BETTER" Hits Newsstands Nationwide Today • Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference • U.S. Institute of Peace Opens Nominations for 2023 Women Building Peace Award • Anaergia Signs Contract to Build State-of-the-Art Food Waste and Wastewater Sludge Co-Digestion Facility at Monterey One Water i • Allego Reports First Quarter 2023 Results; Allego Nearly Triples Charging Revenues in Q1 2023 • Avalon Assisted Living at Hillsborough Partners with Quake Global to Improve Quality of Care. • New Web Addresses Pave the Way for LGBTQ+ Businesses to Thrive and Connect • Milliken & Company Debuts on Newsweek’s Top 100 Global Most Loved Workplaces • Operation Homefront presents Cornerstone Award to Bob Deforge of Pratt & Whitney • KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • The Executive Leadership Council Announces the Appointment of Fabian Milburn as Chief Legal and Human Resources Officer • Founders First Capital Partners Sponsors Women in Cloud to Foster Financial Opportunities for Women Tech Founders • Statement by the Prime Minister on Canadian Armed Forces Day • Baidu's 2022 ESG Report Highlights "Safe and Controllable" as Highest Principle of AI Ethics • Precision BioSciences to Present at Upcoming June Investor Conferences • Framework Incorporating DecisionDx®-SCC Test Results into Clinical Decision-Making for Patients with High-Risk Cutaneous Squ • Cupshe Celebrates 8th Birthday with Exclusive Collection in Collaboration with Chanel Iman, Heather Rae El Moussa, and Brittany • Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States • Changing dishwashing habits can help save more than 3.5 million tonnes of CO2 in Europe

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fidelity National Info

LOS ANGELES , March 22 /Businesswire/ - Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 5, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fidelity National Information Services, Inc. (“Fidelity” or the “Company”) (NYSE: FIS) common stock between February 9, 2021 and February 10, 2023, inclusive (the “Class Period”).

If you suffered a loss on your Fidelity investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Fidelity-National-Information-Services-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On August 4, 2022, Fidelity announced that its Chief Financial Officer planned to step down as Corporate Executive Vice President and CFO. On this news, Fidelity’s stock price fell $7.56, or 7.3%, to close at $96.57 per share on August 4, 2022, thereby injuring investors.

Then, on November 3, 2022, the Company reported that its Merchant Solutions segment – specifically, its latest acquisition, Worldpay – had suffered a “margin contraction of 430 basis points.” On this news, Fidelity’s stock price fell $22.29, or 28%, to close at $56.79 per share on November 3, 2022.

Then, on February 13, 2023, Fidelity announced that it would spin off Worldpay, and in the process, the Company recognized a $17.6 billion write-down on the asset. On this news, Fidelity’s stock price fell $9.43, or 12.5%, to close at $66.00 per share on February 13, 2023, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the integration of Worldpay was not ahead of schedule; (2) the integration of Worldpay was not successfully completed during the Class Period; (3) the increases in revenue synergies were not driven by the Worldpay integration; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Fidelity common stock during the Class Period, you may move the Court no later than May 5, 2023 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.